Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2026)

Treace Medical Concepts has reported Short-term Investments for 5 years, with the latest figure at $42.3 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 32.54% year-over-year to $42.3 million; the trailing twelve-month figure through Mar 2026 stood at $42.3 million (down 32.54% YoY), and the FY2025 full-year result was $37.7 million, down 41.46% from the prior year.
• Short-term Investments for Q1 2026 stood at $42.3 million, up from $37.7 million in the prior quarter.
• The five-year high for Short-term Investments was $141.0 million in Q1 2023, with the low at $37.7 million in Q4 2025.
• Historically, Short-term Investments has averaged $80.1 million across 5 years, with a median of $67.5 million in 2024.
• Annual changes were most pronounced in 2023 — Short-term Investments jumped 78.4% — and 2024, when it plunged 41.64%.
• Treace Medical Concepts' Short-term Investments stood at $61.8 million in 2022, then jumped by 78.4% to $110.2 million in 2023, then sank by 41.64% to $64.3 million in 2024, then plunged by 41.46% to $37.7 million in 2025, then advanced by 12.35% to $42.3 million in 2026.
• The last three Short-term Investments figures came in at $42.3 million (Q1 2026), $37.7 million (Q4 2025), and $49.7 million (Q3 2025), per Business Quant data.